| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 83, 128-133, Copyright © 1983 by American College of Chest Physicians
ARTICLES |
RA DeRemee
The awareness that sarcoidosis can involve intrathoracic lymph nodes and lung parenchyma in sequential fashion evolved during the first half of this century. This awareness resulted in a roentgenographic staging system that has relevance to the course and prognosis, pulmonary function changes, and the symptom of dyspnea. The following definition or roentgenographic staging is proposed as the simplest, most reproducible system based solely on the roentgenographic appearance, avoiding histopathologic and pathophysiologic inferences. Stage I: bilateral hilar lymphadenopathy; stage II: bilateral hilar lymphadenopathy plus parenchymal infiltration; and stage III: parenchymal infiltration without bilateral hilar lymphadenopathy. The early data concerning bronchoalveolar lavage, determination of serum angiotensin-converting enzyme, and gallium 67 citrate scanning appear to have no clear relationships to staging, suggesting that staging continues to have unique value to the clinician in the classification of sarcoidosis and in the delineation of its clinical course and prognosis.
This article has been cited by other articles:
|
|
 |
|
  A. Prasse, D. V. Pechkovsky, G. B. Toews, W. Jungraithmayr, F. Kollert, T. Goldmann, E. Vollmer, J. Muller-Quernheim, and G. Zissel A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18 Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 781 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Marten, E J Rummeny, and C Engelke The CT halo: a new sign in active pulmonary sarcoidosis Br. J. Radiol., December 1, 2004; 77(924): 1042 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rothkrantz-Kos, M. P. van Dieijen-Visser, P. G.H. Mulder, and M. Drent Potential Usefulness of Inflammatory Markers to Monitor Respiratory Functional Impairment in Sarcoidosis Clin. Chem., September 1, 2003; 49(9): 1510 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Grutters, J.-M. Fellrath, L. Mulder, R. Janssen, J. M. M. van den Bosch, and H. van Velzen-Blad Serum Soluble Interleukin-2 Receptor Measurement in Patients With Sarcoidosis: A Clinical Evaluation Chest, July 1, 2003; 124(1): 186 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Visser, K Vos, E Zanelli, W Verduyn, G M T. Schreuder, I Speyer, F C Breedveld, and J M W Hazes Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors Ann Rheum Dis, June 1, 2002; 61(6): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. CAPELLI, A. DI STEFANO, M. LUSUARDI, I. GNEMMI, and C. F. DONNER Increased Macrophage Inflammatory Protein-1alpha and Macrophage Inflammatory Protein-1beta Levels in Bronchoalveolar Lavage Fluid of Patients Affected by Different Stages of Pulmonary Sarcoidosis Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 236 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Abehsera, D. Valeyre, P. Grenier, H. Jaillet, J. P. Battesti, and M. W. Brauner Sarcoidosis with Pulmonary Fibrosis: CT Patterns and Correlation with Pulmonary Function Am. J. Roentgenol., June 1, 2000; 174(6): 1751 - 1757. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. K. Shetty and A. Gedalia Sarcoidosis: A Pediatric Perspective Clinical Pediatrics, December 1, 1998; 37(12): 707 - 717. [Abstract] [PDF]
|
|
|
|
|
|
C. P. WYSER, E. M. van SCHALKWYK, B. ALHEIT, P. G. BARDIN, and J. R. JOUBERT Treatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A . A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., November 1, 1997; 156(5): 1371 - 1376. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
